An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma

  1. Rodríguez Otero, P.
  2. Towle, K.
  3. Cope, S.
  4. Caisip, C.
  5. Davies, F.E.
  6. Delforge, M.
  7. Weisel, K.
  8. Marshall, T.S.
  9. Karampampa, K.
  10. Ayers, D.
  11. Mojebi, A.
  12. Braverman, J.
  13. Farrell, J.
  14. Dhanda, D.
Aldizkaria:
Leukemia and Lymphoma

ISSN: 1029-2403,  1042-8194

Argitalpen urtea: 2023

Alea: 64

Zenbakia: 11

Orrialdeak: 1864-1869

Mota: Gutuna

DOI: 10.1080/10428194.2023.2235042 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus